Cyclophosphamide: Uses, Dosage, and Safety Information

Cyclophosphamide is a medication used to treat a number of cancers, including breast cancer, lymphoma, and leukemia. It’s also used, in selected situations under specialist supervision, to manage certain severe autoimmune diseases, such as lupus nephritis. This drug works by interfering with the growth of rapidly dividing cells, including cancer cells, and by suppressing an overactive immune system in autoimmune conditions.

At a Glance

Common Uses of Cyclophosphamide

• Breast Cancer: Often included in combination chemotherapy regimens.
• Lymphoma: Used in treatment regimens for different lymphoma types.
• Leukemia: Plays a role in treatment regimens for this blood cancer.
• Rheumatoid Arthritis: Cyclophosphamide is not a routine or first-line treatment for rheumatoid arthritis. It may be used only rarely, in selected severe or refractory cases, under specialist supervision.
• Lupus Nephritis: Used as part of selected treatment regimens for severe lupus nephritis (kidney involvement from lupus), under specialist supervision not as a standalone or first-choice option for every case.

Dosage and Administration

There is no single universal cyclophosphamide dose. Your treating specialist determines the dose, route, schedule, and duration based on multiple factors, including:

• The cancer or autoimmune condition being treated
• The specific treatment regimen or protocol
• Whether it’s given orally or intravenously
• Body size
• Blood cell counts
• Kidney and liver function
• Other medicines or chemotherapy agents being used alongside it
• How you respond to treatment and any side effects that develop

Regimens vary substantially by cancer type, autoimmune condition, treatment protocol, and individual patient factors. Never adjust your own dose, route, or schedule always follow your treating specialist’s instructions.

Bladder and Urinary Tract Toxicity (Hemorrhagic Cystitis)

Cyclophosphamide can irritate the bladder lining and, in some cases, cause serious or even life-threatening bleeding (hemorrhagic cystitis). This is a distinct issue from kidney function (see Kidney Considerations below) and specifically involves the bladder and urinary tract.

Depending on the regimen and dose, your care team may use supportive measures to help reduce this risk:

• Mesna: A protective medicine used in selected cyclophosphamide regimens — particularly with certain higher IV doses — to help neutralize a bladder-irritating breakdown product of the drug. Not every regimen requires mesna; whether it’s used depends on your specific treatment plan.
• Hydration and frequent urination: Your care team may advise on fluid intake and voiding frequency around treatment as a supportive measure. This guidance is individualized rather than a fixed schedule for everyone.

Tell your doctor promptly if you notice blood in your urine, pain or burning when urinating, or increased urinary frequency, as this may need to be checked and can sometimes require adjusting or pausing treatment.

Adverse Effects of Cyclophosphamide

• Bone Marrow Suppression (Myelosuppression): Can lower red blood cells, white blood cells, and platelets, increasing the risk of infection, anemia, and bleeding. Regular blood tests are used to monitor this.
• Bladder/Urinary Toxicity: Hemorrhagic cystitis and hematuria see above.
• Cardiotoxicity: Cyclophosphamide can, particularly at higher doses or when combined with certain other chemotherapy drugs, rarely affect the heart. Tell your doctor about any heart disease before starting.
• Pulmonary Toxicity: Rarely, cyclophosphamide can cause lung inflammation, scarring, or other lung problems. Report new or worsening cough, shortness of breath, or breathing difficulty to your treating team promptly.
• Liver Toxicity: Cyclophosphamide can cause liver injury, and rarely, a serious condition called hepatic veno-occlusive disease in some patients. This is uncommon but is why regular monitoring and specialist supervision are important.
• Low Blood Sodium (Hyponatremia): Cyclophosphamide can rarely cause low blood sodium levels, which may require monitoring and medical evaluation.
• Infertility/Reproductive Toxicity: See Fertility section below.
• Secondary Malignancies: Long-term cyclophosphamide use has been linked to a small increased risk of certain other cancers later in life, including bladder cancer (more often in those who’ve had hemorrhagic cystitis) and blood cancers such as myelodysplastic syndrome or leukemia. This risk is weighed by your treating team against the benefit of treating your current condition.
• Embryo-Fetal Toxicity: Can cause serious harm to a developing baby see Pregnancy section below.
• Nausea and Vomiting: Can occur shortly after receiving the drug; anti-nausea medicines are often given alongside it.
• Hair Loss: Common during treatment, usually reversible after treatment ends.
• Impaired Wound Healing: Cyclophosphamide may slow wound healing; tell your surgical team if you have upcoming surgery or a wound.
• Increased Risk of Infections: Due to its suppressive effect on the immune system.

Frequency varies by dose, regimen, and individual factors your treating team can explain which of these risks are most relevant to your specific treatment plan.

Seek urgent medical attention for severe breathing difficulty, chest symptoms, significant bleeding, severe signs of infection, or significant blood in the urine.

Fertility

Cyclophosphamide can affect fertility in both men and women, and this effect can be temporary or permanent depending on the individual, dose, and duration of treatment. If having children in the future is important to you, discuss fertility preservation options (such as sperm or egg/embryo banking) with your doctor before starting treatment, when clinically feasible this timing matters, and preservation is not always possible once treatment has begun.

Contraindications and Important Precautions

Formal contraindications (reasons cyclophosphamide should not be used), based on current prescribing information:

• Known hypersensitivity to cyclophosphamide
• Urinary outflow obstruction

Important precautions (situations requiring careful assessment and monitoring by your treating team, rather than automatic exclusion):

• Severe bone marrow suppression
• Active infections
• Urinary tract problems
• Significant cardiac disease
• Pulmonary (lung) disease
• Liver or kidney impairment
• Other conditions that may increase the risk of toxicity

Drug Interactions

Cyclophosphamide can interact with a range of other medicines, including warfarin and other blood thinners, as well as certain other chemotherapy agents. Give your oncology or rheumatology team a complete list of everything you take — prescription medicines, over-the-counter products, supplements, and herbal products — so they can check for relevant interactions and adjust monitoring if needed.

Pregnancy, Breastfeeding, Liver, and Kidney Considerations

• Pregnancy and Contraception: Cyclophosphamide can cause serious harm to a developing baby and is generally avoided in pregnancy except in specific situations directed by a specialist. Per current prescribing information: females of reproductive potential should use effective contraception during treatment and for up to 1 year after the last dose; males with partners who could become pregnant should use effective contraception during treatment and for 4 months after the last dose. Your treating team will advise on the appropriate method for your situation. Do not stop or change your treatment on your own. Contact your treating team promptly if you become pregnant or think you might be pregnant during treatment.
• Breastfeeding: Breastfeeding is not recommended during cyclophosphamide treatment and for 1 week after the last dose, consistent with current prescribing information. Discuss timing with your treating team before resuming breastfeeding after this period.
• Liver: Cyclophosphamide can cause liver injury, including rare serious effects such as hepatic veno-occlusive disease. Regular monitoring is part of specialist-supervised care.
• Kidney: Kidney function is considered when planning your treatment, and patients with moderate or severe kidney impairment may need closer monitoring for toxicity. This is separate from the bladder/urinary toxicity discussed above, which is a distinct major safety issue in its own right.

Other Precautions

• Vaccines: Because cyclophosphamide affects the immune system, certain vaccines — particularly live vaccines — need to be discussed with your treating team, who can advise on timing relative to your treatment. Not every vaccine is automatically off-limits; this depends on your specific situation.

Popular Brand Names of Cyclophosphamide

In India, cyclophosphamide is sold as Endoxan, while in the United States, it’s commonly known as Cytoxan.

Approximate Price in India

endoXAN Asta 500 mg Injection, 1 vial: MRP around ₹72; discounted pharmacy prices for this and comparable 500 mg cyclophosphamide injection brands commonly range from about ₹36–₹54 per vial, depending on the pharmacy and current discount.

Prices may vary by brand, strength, formulation, pack size, pharmacy, location, and available discounts. Cyclophosphamide is a prescription chemotherapy medicine that is generally administered or procured through supervised medical care rather than routine direct consumer purchase.

How We Can Help

At HealthPil, you can consult a qualified doctor about your condition, treatment questions, and medication-related concerns. Book a consultation.